A Retrospective Analysis of Treatment of Covid-19 with Favipiravir
One of the potential therapeutic agents for treating COVID-19 is favipiravir (FPV). This retrospective study compared the treatment of COVID-19 with (FVP group) or without (control group) favipiravir. Demographic characteristics and initial clinical indicators in the two groups were comparable. The...
Saved in:
Main Authors: | Aigul Utegenova, Sholpan Kulzhanova, Maiya Konkayeva, Zauresh Smagulova, Nazira Beisenbieva, Gulnara Tuleshova |
---|---|
Format: | Article |
Language: | English |
Published: |
Medical University - Pleven
2022-06-01
|
Series: | Journal of Biomedical & Clinical Research |
Subjects: | |
Online Access: | https://jbcr.arphahub.com/article/34627/download/pdf/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
EFFECTIVENESS AND SAFETY OF FAVIPIRAVIR INFUSION IN PATIENTS HOSPITALIZED WITH COVID-19
by: L. A. Balykova, et al.
Published: (2022-03-01) -
Comparative Analysis of the Antiviral Activity of Various Drugs Based on 6-Fluoro-3-Hydroxy-2-Pyrazinecarboxamide (Favipiravir) Against COVID-19
by: S. Ya. Loginova, et al.
Published: (2024-06-01) -
The importance of outpatient etiotropic therapy in patients hospitalized with COVID-19
by: Zh. Zh. Zhanibekov, et al.
Published: (2023-04-01) -
Is The SARS-CoV2 Evolved in Human Being: A prospective Genetic Analysis
by: Salvatore Dimonte, et al.
Published: (2020-12-01) -
Molnupiravir and Nirmatrelvir/Ritonavir: The New Available Antiviral Options for COVID-19
by: Samuel Theodorus Sutanto, et al.
Published: (2023-01-01)